The offer will be Hong Kong Dollar (HKD) 11.00 (EUR 1.06) per share, corresponding to a premium of approximately 34.5%, based on the average closing price over the past 30 trading days. The offer corresponds to a market capitalization of approximately SEK 9.4 billion (EUR 1.08 billion) for all shares in Vinda.

SCA became a part owner in the tissue manufacturer Vinda in 2007 and currently has a 21.7% holding in the company with two representatives on its Board of Directors. Vinda is the third largest tissue company in China, which represents the world’s second largest tissue market. In 2012, Vinda’s sales rose 26% and amounted to approximately SEK 5 billion (EUR 0.6 billion). The company’s operating margin was 12.9%.

“Vinda is a strong player in the Chinese tissue market and has demonstrated healthy growth and profitability. As a majority shareholder, we would see the potential to further strengthen the company to ensure its future competitiveness,” says Jan Johansson, President and CEO of SCA.